ArticleSurgical endoscopy2026
Long-term outcomes of laparoscopic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: comparable with the open approach for limited colorectal peritoneal metastases (KNUCRC-25CR1).
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSome patients with early-stage colorectal peritoneal metastasis require cytoreductive surgery (CRS) to a limited extent. This study aimed to evaluate the long-term outcomes of laparoscopic versus open surgery for limited peritoneal metastases, including survival outcomes and progression patterns.
methodsThis retrospective study analyzed data from 68 patients who underwent CRS and hyperthermic intraperitoneal chemotherapy (HIPEC) at a single university hospital between January 2014 and December 2021. Postoperative and survival outcomes were compared between the laparoscopic CRS (L-CRS) and open CRS (O-CRS) groups before and after propensity-score (PS) matching. Primary outcomes were overall survival (OS), progression-free survival (PFS), and peritoneal PFS (P-PFS).
resultsOf the 68 patients, 42 underwent L-CRS, and 26 underwent O-CRS. After PS matching, preoperative characteristics of the patients were well balanced. Postoperative complications were not different between the two groups. The length of hospital stay was significantly shorter in the L-CRS group than in the O-CRS group. The median OS was 37.3 (95% confidence interval [CI] 15.6-59.0) months in the L-CRS group and 34.1 (95% CI 1.9-66.4) months in the O-CRS group (p = 0.535). PFS and P-PFS were not significantly different between the two groups. Multivariate analysis revealed that extraperitoneal metastasis status was the only significant factor associated with OS and PFS. Progression patterns were not different between the two groups.
conclusionsL-CRS and HIPEC could achieve comparable oncologic outcomes to open surgery in highly selected patients with limited peritoneal metastases from colorectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.